arrow
K

Khatija Ahmed

Setshaba Research Centre
H指数:34
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evaluating the effects of a multi-level intervention on young women’s contraceptive use: sexual and reproductive health results of a cluster-randomized factorial-design study in Tshwane, South Africa

评估多层次干预对年轻女性避孕使用的影响:南非茨瓦内区群组随机析因设计研究的性与生殖健康结果

2026-07-010
OA
Viral variant but not host factors associate with SARS-CoV-2 viral kinetics

病毒变体而非宿主因素与SARS-CoV-2病毒动力学相关联

2026-04-170
OAAI
Timing of household contact investigation for tuberculosis among rural and urban populations in South Africa (Kharituwe study): a pragmatic individually randomized controlled trial

南非农村和城市人口中结核病家庭接触者调查的时机(Kharituwe研究):一项实用的个体随机对照试验

2026-01-160
OAAI
I needed somebody to encourage me to take it [PrEP], maybe it would have protected me and the baby: a qualitative study to understand prenatal oral PrEP use among pregnant adolescent girls and young women in Tshwane, South Africa

我需要有人鼓励我服用[PrEP],也许它本可以保护我和孩子:一项旨在了解南非茨瓦内市孕妇及年轻女性孕期口服PrEP使用情况的研究。

2025-10-150
OAAI
Molecular Epidemiology of Mycobacterium tuberculosis Across 3 Distinct Geographic Sites in South Africa

南非3个不同地理区域结核分枝杆菌(Mycobacterium tuberculosis)的分子流行病学

2025-07-010
PRE
Innovative timing strategies for tuberculosis household contact investigation: cost-effectiveness analysis from a randomized trial in rural and urban South Africa (Kharituwe Study)

结核病家庭接触者调查的创新性时间策略:来自南非农村和城市地区随机试验的成本效益分析(Kharituwe研究)

2025-06-010
PRE
Effect of contraceptive methods on the vaginal microbiome and host immune factors

避孕方法对阴道微生物组和宿主免疫因素的影响

2025-05-080
OA
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M™ adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial
2024-12-120
OAAI
Comparing the accuracy of inflammation detection using the lateral flow point of care Genital InFlammation Test (GIFT) interpreted by visual inspection versus automated reader
2023-12-170
OA
Incidence of Respiratory Syncytial Virus-Associated Lower Respiratory Tract Illness in Infants in Low- and Middle-Income Regions During the Coronavirus Disease 2019 Pandemic

冠状病毒2019大流行期间中低收入地区婴儿呼吸道合胞病毒相关下呼吸道疾病的发病率

2023-12-013
OAAI
ChAdOx1 nCoV-19 (AZD1222) vaccine-induced Fc receptor binding tracks with differential susceptibility to COVID-19

ChAdOx1 nCoV-19 (AZD1222) 疫苗诱导的Fc受体结合轨道对新型冠状病毒肺炎的敏感性不同

2023-06-157
OAAI
Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial

ChAdOx1 nCoV-19 (AZD1222) 疫苗和针对omicron BA.1和BA.4变体的杂交体液免疫在疫苗接种后6个月的持久性 (COV005): 一项随机1b-2a期试验的事后分析

2023-03-0114
OAAI
Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa

健康诊所的污名及其对青春期女孩和年轻妇女使用PrEP的影响: 南非的观点冲突

2022-10-1420
OAAI
Immunological non-inferiority of a new fully liquid presentation of the MenACWY-CRM vaccine to the licensed vaccine: results from a randomized, controlled, observer-blind study in adolescents and young adults
2021-10-063
OAAI
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
2021-05-20381
OAAI